|
今天花时间看了下PulseMedica官网更新的最初的投资机构Inovait对他们的报告,里面讲的很充分也给出了市场预期,不过这里有句话:
Having received Investigational Testing Authorization from Health Canada for its first-in-human clinical trial, PulseMedica is now validating its device’s capabilities to obtain the necessary documentation and approval from Health Canada and, eventually, the FDA to bring the device to market.
想请教下各位大神,这里的first-in-human clinical trial是之前我们看到的在加拿大和巴拿马计划开展的数据收集,还是新的trail?因为我在加拿大的官网上并没有搜到pulsemedica的信息,这个canada health好像也没有一个独立网站。
另外就是看样子还是要走FDA?假设只是Canada Health的审核的话,这个实验如果可以说服它们,那设备就可以上市了?
https://inovait.ca/pulsemedica-i ... eoretinal-diseases/
原文也发一下,应该不用翻墙,可直接阅读
|
|